Comment
doi: 10.1038/nature15213.
Epub 2015 Sep 2.
Cancer: Repositioned to kill stem cells
Affiliations
- PMID: 26331538
- DOI: 10.1038/nature15213
Item in Clipboard
Comment
Cancer: Repositioned to kill stem cells
Nature.
.
Free article
No abstract available
Comment on
-
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.Nature. 2015 Sep 17;525(7569):380-3. doi: 10.1038/nature15248. Epub 2015 Sep 2. Nature. 2015. PMID: 26331539
Similar articles
-
Haematological cancer: Repositioned to attack CML cells.Nat Rev Clin Oncol. 2015 Nov;12(11):624. doi: 10.1038/nrclinonc.2015.166. Epub 2015 Sep 22. Nat Rev Clin Oncol. 2015. PMID: 26391777 No abstract available.
-
PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells.Blood Cancer J. 2016 Jan 8;6(1):e377. doi: 10.1038/bcj.2015.109. Blood Cancer J. 2016. PMID: 26745851 Free PMC article. No abstract available.
-
PPARγ: Welcoming the New Kid on the CML Stem Cell Block.Cancer Cell. 2015 Oct 12;28(4):409-411. doi: 10.1016/j.ccell.2015.09.017. Cancer Cell. 2015. PMID: 26461088
-
Interferon in chronic myeloid leukaemia: past and future.Best Pract Res Clin Haematol. 2009 Sep;22(3):315-29. doi: 10.1016/j.beha.2009.10.005. Best Pract Res Clin Haematol. 2009. PMID: 19959083 Review.
-
[Overcoming imatinib resistance].Nihon Rinsho. 2007 Jan 28;65 Suppl 1:399-403. Nihon Rinsho. 2007. PMID: 17474437 Review. Japanese. No abstract available.
Cited by
-
Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia.Cells. 2020 Aug 19;9(9):1921. doi: 10.3390/cells9091921. Cells. 2020. PMID: 32824945 Free PMC article. Review.
-
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Front Endocrinol (Lausanne). 2017 Feb 22;8:31. doi: 10.3389/fendo.2017.00031. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28275367 Free PMC article. Review.
